BRIEF published on 08/08/2025 at 23:35, 9 months 18 days ago La FDA approuve le système Genio® de Nyxoah pour le traitement de l'apnée obstructive du sommeil Approbation De La FDA Nyxoah Apnée Obstructive Du Sommeil Commercialisation Aux États-Unis Système Genio
PRESS RELEASE published on 08/08/2025 at 23:30, 9 months 18 days ago Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea Nyxoah receives FDA approval for Genio System, advancing OSA treatment with bilateral stimulation and leadless technology. U.S. commercialization launched FDA Approval Nyxoah Obstructive Sleep Apnea Neuromodulation Genio System
BRIEF published on 07/28/2025 at 22:10, 9 months 29 days ago Nyxoah’s DREAM Study Data Featured in Clinical Journal Obstructive Sleep Apnea DREAM Study Clinical Outcomes Genio® System Patient Satisfaction
BRIEF published on 07/28/2025 at 22:10, 9 months 29 days ago Les données de l'étude DREAM de Nyxoah présentées dans une revue clinique Résultats Cliniques Apnée Obstructive Du Sommeil Étude DREAM Système Genio® Satisfaction Des Patients
PRESS RELEASE published on 07/28/2025 at 22:05, 9 months 29 days ago Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Nyxoah's DREAM pivotal study data on Genio system for OSA treatment published in Journal of Clinical Sleep Medicine. Study shows high patient satisfaction & improved quality of life Sleep Medicine Nyxoah Genio System DREAM Pivotal Study OSA Treatment
BRIEF published on 05/14/2025 at 07:05, 1 year ago Nyxoah Reports First Quarter 2025 Financial and Operating Results Financial Results FDA Approval Nyxoah Q1 2025 Genio System
BRIEF published on 05/14/2025 at 07:05, 1 year ago Nyxoah publie ses résultats financiers et opérationnels du premier trimestre 2025 Résultats Financiers Approbation De La FDA Nyxoah Système Genio T1 2025
PRESS RELEASE published on 05/14/2025 at 07:00, 1 year ago Nyxoah Reports First Quarter Financial and Operating Results Nyxoah reports financial and operating results for the first quarter of 2025, including progress towards FDA PMA approval for the Genio® system. Revenue €1.1 million. Cash position €63.0 million Financial Results FDA Approval Operating Highlights Nyxoah Genio® System
BRIEF published on 04/08/2025 at 07:05, 1 year 1 month ago Nyxoah informe sur le processus d'approbation du système Genio par la FDA Technologie Médicale Approbation De La FDA Nyxoah Apnée Obstructive Du Sommeil Système Genio
BRIEF published on 04/08/2025 at 07:05, 1 year 1 month ago Nyxoah Updates on FDA Approval Process for Genio System FDA Approval Medical Technology Nyxoah Obstructive Sleep Apnea Genio System
Published on 05/27/2026 at 02:10, 3 hours 27 minutes ago Western Investment Company Reports First Quarter 2026 Results and Announces Executive Personnel Changes
Published on 05/27/2026 at 01:45, 3 hours 52 minutes ago Organto Foods Announces Record First Quarter 2026 Financial Results
Published on 05/27/2026 at 00:25, 5 hours 12 minutes ago Revolve Reports Q3 F2026 Results Backed by Strong Progress Across North American Portfolio
Published on 05/26/2026 at 22:15, 7 hours 22 minutes ago LaFleur Announces Bought Deal Equity Offerings for Gross Proceeds of C$8 Million
Published on 05/26/2026 at 22:01, 7 hours 36 minutes ago Kidoz Inc. Reports Q1 2026 Financial Results with YoY Revenue Growth, Accelerating Strategic Investment in AI
Published on 05/26/2026 at 18:50, 10 hours 47 minutes ago The AI Gold Rush Is Running Into a Margin Problem
Published on 05/26/2026 at 18:30, 11 hours 7 minutes ago H2APEX publishes financial figures for the first quarter of 2026 and confirms forecast
Published on 05/26/2026 at 17:45, 11 hours 52 minutes ago FIGEAC AÉRO: EXTENSION DU PARTENARIAT AVEC UN CLIENT AMÉRICAIN
Published on 05/26/2026 at 17:30, 12 hours 7 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 05/26/2026 (French only)
Published on 05/26/2026 at 17:30, 12 hours 7 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 26 05 2026
Published on 05/26/2026 at 18:39, 10 hours 57 minutes ago Déclaration des opérations d'achats d'actions réalisées le 18 mai 2026
Published on 05/26/2026 at 18:39, 10 hours 57 minutes ago Reporting on share buyback transactions carried out on May 18, 2026
Published on 05/26/2026 at 17:45, 11 hours 52 minutes ago EURAZEO INVESTS IN BABYLON, A FRENCH OPERATOR OF NEXT-GENERATION APARTHOTELS
Published on 05/26/2026 at 17:45, 11 hours 52 minutes ago EURAZEO INVESTIT DANS BABYLON, SPÉCIALISTE FRANÇAIS DES APARTHOTELS DE NOUVELLE GÉNÉRATION
Published on 05/26/2026 at 17:40, 11 hours 57 minutes ago LDC : Nombre total de droits de vote et d'actions composant le capital au 30.04.26.
